Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoine Pariente

Showing results (111-120 of 220) with videos related to

Pageof 22
Sort By:
Drug Safety|February 18, 2022
High-Dimensional Propensity Score-Adjusted Case-Crossover for Discovering Adverse Drug Reactions from Computerized Administrative Healthcare DatabasesEtienne Volatier, Francesco Salvo, Antoine Pariente, et al.
Therapie|February 25, 2023
[Performing pharmacoepidemiological studies using the French health insurance data warehouse (SNDS): How to translate guidelines into practice]Sibylle de Germay, Cécile Conte, Joëlle Micallef, et al.
Frontiers in Pharmacology|April 11, 2019
Risk of Drug-Drug Interactions in Out-Hospital Drug Dispensings in France: Results From the DRUG-Drug Interaction Prevalence StudyLouis Létinier, Sébastien Cossin, Yohann Mansiaux, et al.
Drug Safety|July 1, 2017
Impact of Medicine Withdrawal on Reporting of Adverse Events Involving Therapeutic Alternatives: A Study from the French Spontaneous Reporting DatabaseCécile Pageot, Julien Bezin, Andy Smith, et al.
Frontiers in Psychiatry|July 18, 2022
Oral Morphine as an Alternative Substitution Treatment for Opioid Use Disorder, a Rare but Non-risk-free UseCélian Bertin, Julien Bezin, Chouki Chenaf, et al.
Clinical Pharmacology and Therapeutics|May 5, 2026
Reply to "A Comment about AI Methods that May Help Advance Pharmacovigilance"Charles Khouri, Alex Hlavaty, Michele Fusaroli, et al.
European Journal of Epidemiology|September 21, 2022
Impact of the COVID-19 pandemic and its control measures on cardiovascular and antidiabetic drugs use in France in 2020: a nationwide repeated cohort studyClément Mathieu, Elodie Pambrun, Anne Bénard-Laribière, et al.
European Archives of Psychiatry and Clinical Neuroscience|May 28, 2018
Antidepressants during pregnancy: a French drug utilisation study in EFEMERIS cohortCaroline Hurault-Delarue, Isabelle Lacroix, Anne Bénard-Laribière, et al.
Clinical Pharmacology and Therapeutics|December 21, 2025
The Rising Misuse of Pharmacovigilance Reporting Systems: A Threat to Evidence-Based MedicineCharles Khouri, Alex Hlavaty, Michele Fusaroli, et al.
Drug Safety|April 19, 2014
Fibrates and risk of cancer in tissues with high PPAR-α concentration: a nested case-control studyFrancesco Salvo, Fabienne Bazin, Aude Kostrzewa, et al.
Pageof 22

Showing results (111-120 of 220) with videos related to

Sort By:
Pageof 22
Drug Safety|February 18, 2022
High-Dimensional Propensity Score-Adjusted Case-Crossover for Discovering Adverse Drug Reactions from Computerized Administrative Healthcare DatabasesEtienne Volatier, Francesco Salvo, Antoine Pariente, et al.
Therapie|February 25, 2023
[Performing pharmacoepidemiological studies using the French health insurance data warehouse (SNDS): How to translate guidelines into practice]Sibylle de Germay, Cécile Conte, Joëlle Micallef, et al.
Frontiers in Pharmacology|April 11, 2019
Risk of Drug-Drug Interactions in Out-Hospital Drug Dispensings in France: Results From the DRUG-Drug Interaction Prevalence StudyLouis Létinier, Sébastien Cossin, Yohann Mansiaux, et al.
Drug Safety|July 1, 2017
Impact of Medicine Withdrawal on Reporting of Adverse Events Involving Therapeutic Alternatives: A Study from the French Spontaneous Reporting DatabaseCécile Pageot, Julien Bezin, Andy Smith, et al.
Frontiers in Psychiatry|July 18, 2022
Oral Morphine as an Alternative Substitution Treatment for Opioid Use Disorder, a Rare but Non-risk-free UseCélian Bertin, Julien Bezin, Chouki Chenaf, et al.
Clinical Pharmacology and Therapeutics|May 5, 2026
Reply to "A Comment about AI Methods that May Help Advance Pharmacovigilance"Charles Khouri, Alex Hlavaty, Michele Fusaroli, et al.
European Journal of Epidemiology|September 21, 2022
Impact of the COVID-19 pandemic and its control measures on cardiovascular and antidiabetic drugs use in France in 2020: a nationwide repeated cohort studyClément Mathieu, Elodie Pambrun, Anne Bénard-Laribière, et al.
European Archives of Psychiatry and Clinical Neuroscience|May 28, 2018
Antidepressants during pregnancy: a French drug utilisation study in EFEMERIS cohortCaroline Hurault-Delarue, Isabelle Lacroix, Anne Bénard-Laribière, et al.
Clinical Pharmacology and Therapeutics|December 21, 2025
The Rising Misuse of Pharmacovigilance Reporting Systems: A Threat to Evidence-Based MedicineCharles Khouri, Alex Hlavaty, Michele Fusaroli, et al.
Drug Safety|April 19, 2014
Fibrates and risk of cancer in tissues with high PPAR-α concentration: a nested case-control studyFrancesco Salvo, Fabienne Bazin, Aude Kostrzewa, et al.
Pageof 22